发信人: possible (yes), 信区: Biology
标 题: Re: 一个来自祖国大陆的博士后的故事
发信站: BBS 未名空间站 (Thu Sep 22 20:48:15 2005)

1. Jiang SB, He YX, Liu SW
SARS vaccine development
EMERGING INFECTIOUS DISEASES 11 (7): 1016-1020 JUL 2005
Times Cited: 0

2. Wang LX, Song HJ, Liu SW, et al.
Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: Effects of glycosylation
on the anti-HIV activity and alpha-helix bundle-forming ability of peptide
C34
CHEMBIOCHEM 6 (6): 1068-1074 JUN 2005
Times Cited: 1

3. Liu SW, Lu H, Zhao Q, et al.
Theaflavin derivatives in black tea and catechin derivatives in green tea
inhibit HIV-1 entry by targeting gp41
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1723 (1-3): 270-281 MAY 25 2005

Times Cited: 0

4. Liu SW, Lu H, Neurath AR, et al.
Combination of candidate microbicides cellulose acetate 1,2-
benzenedicarboxylate and UC781 has synergistic and complementary effects
against human immunodeficiency virus type 1 infection
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 49 (5): 1830-1836 MAY 2005
Times Cited: 0

5. Liu SW, Lu H, Niu J, et al.
Different from the HIV fusion inhibitor C34, the anti-HIV drug fuzeon (T-20)
inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120
JOURNAL OF BIOLOGICAL CHEMISTRY 280 (12): 11259-11273 MAR 25 2005
Times Cited: 1

6. He YX, Zhu QY, Liu SW, et al.
Identification of a critical neutralization determinant of severe acute
respiratory syndrome (SARS)-associated coronavirus: Importance for designing
SARS vaccines
VIROLOGY 334 (1): 74-82 MAR 30 2005
Times Cited: 2

7. He YX, Zhou YS, Wu H, et al.
Mapping of antigenic sites on the nucleocapsid protein of the severe acute
respiratory syndrome coronavirus
JOURNAL OF CLINICAL MICROBIOLOGY 42 (11): 5309-5314 NOV 2004
Times Cited: 2

8. Jiang SB, Lu H, Liu SW, et al.
N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1
entry inhibitors that interfere with the gp41 six-helix bundle formation and
block virus fusion
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 48 (11): 4349-4359 NOV 2004
Times Cited: 2

9. He YX, Zhou YS, Liu SW, et al.
Receptor-binding domain of SARS-CoV spike protein induces highly potent
neutralizing antibodies: implication for developing subunit vaccine
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 324 (2): 773-781 NOV 12
2004
Times Cited: 13

10. Liu SW, Jiang SB
High throughput screening and characterization of HIV-1 entry inhibitors
targeting gp41: Theories and techniques
CURRENT PHARMACEUTICAL DESIGN 10 (15): 1827-1843 2004
Times Cited: 4

11. Liu SW, Xiao GF, Chen YB, et al.
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-
associated coronavirus: implications for virus fusogenic mechanism and
identification of fusion inhibitors
LANCET 363 (9413): 938-947 MAR 20 2004
Times Cited: 43

12. Lu L, Liu SW, Jiang SB, et al.
Tannin inhibits HIV-1 entry by targeting gp41
ACTA PHARMACOLOGICA SINICA 25 (2): 213-218 FEB 2004
Times Cited: 0

13. Liu SW, Zhao Q, Jiang SB
Determination of the HIV-1 gp41 fusogenic core conformation modeled by
synthetic peptides: applicable for identification of HIV-1 fusion inhibitors
PEPTIDES 24 (9): 1303-1313 SEP 2003
Times Cited: 5

14. Liu SW, Boyer-Chatenet L, Lu H, et al.
Rapid and automated fluorescence-linked immunosorbent assay for high-
throughput screening of HIV-1 fusion inhibitors targeting gp41
JOURNAL OF BIOMOLECULAR SCREENING 8 (6): 685-693 DEC 2003
Times Cited: 3

15. Liu SW, Jiang SB, Wu ZH, et al.
Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from
extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte
LIFE SCIENCES 71 (15): 1779-1791 AUG 30 2002
Times Cited: 4




--

※ 来源:·BBS 未名空间站 http://mitbbs.com·[FROM: 129.176.]